Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Conjugate Vaccines Market, by Region, 2019-2029 (USD Billion)
1.2.2. Conjugate Vaccines Market, by Type, 2019-2029 (USD Billion)
1.2.3. Conjugate Vaccines Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Conjugate Vaccines Market, by Pathogen Type, 2019-2029 (USD Billion)
1.2.5. Conjugate Vaccines Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Conjugate Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Conjugate Vaccines Market Dynamics
3.1. Conjugate Vaccines Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Government Approvals for Conjugate Vaccines
3.1.1.2. Rising Prevalence of Pneumococcal Disease
3.1.2. Market Challenges
3.1.2.1. Rising side effects associated with the conjugate vaccine
3.1.3. Market Opportunities
3.1.3.1. Constant R&D activities for the development of effective vaccines
Chapter 4. Global Conjugate Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Conjugate Vaccines Market, by Type
6.1. Market Snapshot
6.2. Global Conjugate Vaccines Market by Type, Performance - Potential Analysis
6.3. Global Conjugate Vaccines Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Conjugate Vaccines Market, Sub Segment Analysis
6.4.1. Monovalent Conjugate Vaccines
6.4.2. Multivalent Conjugate Vaccines
Chapter 7. Global Conjugate Vaccines Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Conjugate Vaccines Market by Disease Indication, Performance - Potential Analysis
7.3. Global Conjugate Vaccines Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Conjugate Vaccines Market, Sub Segment Analysis
7.4.1. Pneumococcal
7.4.2. Influenza
7.4.3. Diphtheria Tetanus and Pertussis (DTP)
7.4.4. Meningococcal
7.4.5. Others
Chapter 8. Global Conjugate Vaccines Market, by Pathogen Type
8.1. Market Snapshot
8.2. Global Conjugate Vaccines Market by Pathogen Type, Performance - Potential Analysis
8.3. Global Conjugate Vaccines Market Estimates & Forecasts by Pathogen Type 2019-2029 (USD Billion)
8.4. Conjugate Vaccines Market, Sub Segment Analysis
8.4.1. Bacterial Conjugate Vaccine
8.4.2. Viral Conjugate Vaccine
8.4.3. Combination (Viral and Bacterial) Conjugate Vaccine
Chapter 9. Global Conjugate Vaccines Market, by End User
9.1. Market Snapshot
9.2. Global Conjugate Vaccines Market by End User, Performance - Potential Analysis
9.3. Global Conjugate Vaccines Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
9.4. Conjugate Vaccines Market, Sub Segment Analysis
9.4.1. Pediatrics
9.4.2. Adults
Chapter 10. Global Conjugate Vaccines Market, Regional Analysis
10.1. Conjugate Vaccines Market, Regional Market Snapshot
10.2. North America Conjugate Vaccines Market
10.2.1. U.S. Conjugate Vaccines Market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.3. Pathogen Type breakdown estimates & forecasts, 2019-2029
10.2.1.4. End User breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Conjugate Vaccines Market
10.3. Europe Conjugate Vaccines Market Snapshot
10.3.1. U.K. Conjugate Vaccines Market
10.3.2. Germany Conjugate Vaccines Market
10.3.3. France Conjugate Vaccines Market
10.3.4. Spain Conjugate Vaccines Market
10.3.5. Italy Conjugate Vaccines Market
10.3.6. Rest of Europe Conjugate Vaccines Market
10.4. Asia-Pacific Conjugate Vaccines Market Snapshot
10.4.1. China Conjugate Vaccines Market
10.4.2. India Conjugate Vaccines Market
10.4.3. Japan Conjugate Vaccines Market
10.4.4. Australia Conjugate Vaccines Market
10.4.5. South Korea Conjugate Vaccines Market
10.4.6. Rest of Asia Pacific Conjugate Vaccines Market
10.5. Latin America Conjugate Vaccines Market Snapshot
10.5.1. Brazil Conjugate Vaccines Market
10.5.2. Mexico Conjugate Vaccines Market
10.6. Rest of The World Conjugate Vaccines Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Novartis AG
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Neuron Biotech
11.2.3. Serum Institute of India
11.2.4. Pfizer, Inc.
11.2.5. Sanofi Pasteur
11.2.6. Bharat Biotech
11.2.7. Biological E Ltd.
11.2.8. GlaxoSmithKline, plc.
11.2.9. Merck and Company
11.2.10. CSL Limited
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption



List of Figures


FIG 1. Global Conjugate Vaccines Market, research methodology
FIG 2. Global Conjugate Vaccines Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Conjugate Vaccines Market, key trends 2021
FIG 5. Global Conjugate Vaccines Market, growth prospects 2022-2029
FIG 6. Global Conjugate Vaccines Market, porters 5 force model
FIG 7. Global Conjugate Vaccines Market, pest analysis
FIG 8. Global Conjugate Vaccines Market, value chain analysis
FIG 9. Global Conjugate Vaccines Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Conjugate Vaccines Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Conjugate Vaccines Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Conjugate Vaccines Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Conjugate Vaccines Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Conjugate Vaccines Market, regional snapshot 2019 & 2029
FIG 15. North America Conjugate Vaccines Market 2019 & 2029 (USD Billion)
FIG 16. Europe Conjugate Vaccines Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Conjugate Vaccines Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Conjugate Vaccines Market 2019 & 2029 (USD Billion)
FIG 19. Global Conjugate Vaccines Market, company Market share analysis (2021)
List of Tables and figures and dummy in nature, final lists may vary in the final deliverable




 

List of Tables


TABLE 1. Global Conjugate Vaccines Market, report scope
TABLE 2. Global Conjugate Vaccines Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Conjugate Vaccines Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Conjugate Vaccines Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 5. Global Conjugate Vaccines Market estimates & forecasts by Pathogen Type 2019-2029 (USD Billion)
TABLE 6. Global Conjugate Vaccines Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 7. Global Conjugate Vaccines Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Conjugate Vaccines Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Conjugate Vaccines Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Conjugate Vaccines Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Conjugate Vaccines Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Conjugate Vaccines Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Conjugate Vaccines Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Conjugate Vaccines Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Conjugate Vaccines Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Conjugate Vaccines Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Conjugate Vaccines Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Conjugate Vaccines Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Conjugate Vaccines Market
TABLE 72. List of primary sources, used in the study of global Conjugate Vaccines Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of Tables and figures and dummy in nature, final lists may vary in the final deliverable